Ad Hoc Capital Injections

Latvia: Parex Bank Capital Injection, 2008

Purpose

Latvian authorities injected capital to meet CAR requirements

Key Terms

  • Announcement Date
    Nov. 24, 2008
  • Operational Date
    May 11, 2009
  • Date of Final Capital Injection
    Date of Final Capital Injection: Citadele – July 29, 2010; Reverta – November 2011
  • End Date
    Citadele: equity shares sold April 20, 2015, subordinated debt repaid to the LPA Jan. 4, 2017; Reverta: ongoing
  • Source(s) of Funding
    Treasury lent funds to the LPA to recapitalize Parex
  • Administrator
    Cabinet of Ministers, LPA, Treasury
  • Size
    Tier 1: LVL 313.6 million; Tier 2: LVL 50.3 million; Liquidity conversion: LVL 152.5 million
  • Capital Characteristics
    Ordinary shares qualifying as Tier 1; subordinated term debt qualifying as Tier 2
  • Bail-in Terms
    The two majority shareholders received a token LVL 2 for 55.4 million shares (85%) in Parex; minority shareholders and subordinated debtholders ultimately received nothing for their investments; senior creditors and insured depositors were fully protected
  • Outcomes
    EUR 428.8 million in losses on the capital injection as of December 2022
  • Notable Features
    Conversion of liquidity support to equity; divergent treatment of majority and minority shareholders; EBRD participation; freeze on legacy depositors until January 2012

Key Design Decisions

Purpose 1

Part of a Package 1

Administration 1

Governance 1

Communication 1

Treatment of Creditors and Equity Holders 1

Capital Characteristics 1

Source and Size of Funding 1

Timing 1

Restructuring Plan 1

Treatment of Board and Management 1

Other Conditions 1

Regulatory Relief 1

Exit Strategy 1

Key Program Documents

Taxonomy

Intervention Categories:

  • Ad Hoc Capital Injections

Institutions:

  • Parex

Countries and Regions:

  • Latvia

Crises:

  • Global Financial Crisis